Highly porous hybrid metal-organic nanoparticles loaded with gemcitabine-monophosphate: a multimodal approach to improve chemo and radiotherapy.
Nanomedicine recently emerge as a novel strategy to improve the performance of radiotherapy. Here we report the first application of an intrinsic radioenhancer, nanoscale metal-organic frameworks (nanoMOFs), loaded with an anticancer drug (Gemcitabine-monophosphate, Gem-MP), a highly effective radiosensitizer for cancer treatment. Iron trimesate nanoMOFs possess a regular porous structure with oxocentered Fe trimers separated by distances of around 5 Å (trimesate linkers). This peculiar configuration is favorable to diffuse in surrounding water the electrons emitted from nanoMOFs due to activation by γ radiation. The hydroxyl radicals generated by electron water-induced radiolysis lead to nanoscale damages. Finally, non-toxic nanoMOFs are shown to efficiently improve γ-ray efficacy for cancer cells eradication. On top of this effect, nanoMOFs act as "Trojan horses" significantly penetrating inside cancer cells, carrying their Gem-MP cargo to interfere with DNA repair. By displaying different mechanisms of action, both nanoMOFs and incorporated Gem-MP synergistically contribute to improve radiation efficacy. The radiation enhancement factor of Gem-MP loaded nanoMOFs reaches 1.8, which is to the best of our knowledge, the highest value ever reported. These results pave the way towards the design of engineered nanoparticles in which each component synergistically plays a role in cancer treatment by radiotherapy.